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BACKGROUND: Prenatal bisphenol A (BPA) exposure has been associated with adverse neurodevelopment in epidemiological studies. However, prior
studies had limited statistical power to examine sex-specific effects, and few examined child cognition.
OBJECTIVES:We estimated the association between prenatal BPA exposure and child neurobehavior at 3 y of age in a prospective cohort of 812 moth-
ers and their children.
METHODS: We measured BPA concentration in urine samples collected at ∼ 12 wk gestation among women enrolled in a 10-city Canadian cohort
study. At approximately 3 y of age, we assessed children’s cognitive abilities with the Wechsler Primary and Preschool Scale of IntelligenceE–III
(WPPSI-III) and two scales of the Behavior Rating Inventory of Executive Function–Preschool (BRIEF-P). Parents reported children’s behavior using
the Behavior Assessment System for Children–2 (BASC-2) and the Social Responsiveness ScaleE–2 (SRS-2). We estimated covariate-adjusted dif-
ferences in neurobehavioral outcomes with a doubling in BPA concentration and sex-specific associations.
RESULTS: BPA was not associated with WPPSI-III scores; child sex did not modify these associations. The association between BPA and BRIEF-P
scores was modified by child sex (BPA× sex p-values≤ 0:03). For example, a doubling of BPA concentration was associated with 1-point (95% CI:
0.3, 1.7) poorer working memory in boys and 0.5-point (95% CI: −1:1, 0.1) better scores in girls. BPA was not associated with most BASC-2 scales;
however, it was associated with more internalizing and somatizing behaviors in boys, but not in girls (BPA× sex p-values≤ 0:08). A doubling of
BPA concentration was associated with poorer SRS-2 scores [b=0:3 ( 95% CI: 0, 0.7)]; this association was not modified by sex.
CONCLUSION: Prenatal urinary BPA concentration was associated with some aspects of child behavior in this cohort, and some associations were
stronger among boys. https://doi.org/10.1289/EHP984
Introduction
Bisphenol A (BPA) is a high-production-volume chemical that is
used to produce polycarbonate plastics and resins used in some
food can linings, medical equipment, thermal receipts, and other
consumer products (Chapin et al. 2008; Ehrlich et al. 2014).
Exposure is ubiquitous among people in industrialized countries
and is predominantly from diet (Casas et al. 2011; von Goetz et al.
2010). There is some evidence that prenatal BPA exposure may
increase the risk of neurobehavioral disorders in children (Braun
2016; Chapin et al. 2008). Some experimental studies in rodents
suggest that prenatal BPA exposure is associated with behavior
problems and that these effects may be sex-specific (Rebuli and
Patisaul 2015; Rosenfeld 2015); however, in other studies, no
effects of BPA on rodent neurobehavior were observed (Rebuli
et al. 2015). Prenatal exposure to BPA may increase the risk of
neurobehavioral disorders by affecting thyroid or gonadal hor-
mones or neurotransmitter systems, which are both necessary for
proper brain development (Castro et al. 2015; Meeker et al. 2010;
Romano et al. 2015). BPAmay also affect the production ormetab-
olism of gonadal hormones, which are an important determinant of
sexually dimorphic brain development; thus, BPA may differen-
tially affect neurodevelopment in males and females (Arnold
2009;Matthews et al. 2001; Zhang et al. 2011).
Several epidemiological studies have reported that maternal
urinary BPA concentration during pregnancy is associated with
adverse behavioral outcomes (Braun et al. 2011; Casas et al.
2015; Evans et al. 2014; Harley et al. 2013; Roen et al. 2015),
whereas others have not (Miodovnik et al. 2011). The presence
and direction of specific associations between BPA exposure and
child neurobehavior has been heterogeneous in these studies.
This variation may arise from differences in study design features
and from misclassification of BPA exposure that is a result of the
high within-person variability of urinary BPA concentrations
(Braun et al. 2012). In addition, some studies have reported that
child sex modifies the association between BPA and neurobehav-
ior, but the modest sample size of these studies may have lim-
ited their statistical power to identify sex-specific associations.
Finally, studies in animals show that gestational BPA exposure
may affect specific aspects of cognition, such as memory and
learning (Jašarević et al. 2013; Wang et al. 2014), but few stud-
ies have examined the relationship between prenatal BPA ex-
posure and children’s cognitive abilities (Braun et al. 2011;
Casas et al. 2015).
To precisely estimate the potential neurotoxic effects of BPA
exposure, we examined the relationship between maternal urinary
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BPA concentrations measured during pregnancy and children’s
behavior and cognitive abilities at 3 y of age in a prospective
cohort study from Canada with follow-up data on 812 children.
Methods
Study Participants
We used data from the Maternal–Infant Research on Environmen-
tal Chemicals (MIREC) study, a prospective cohort that recruited
2,000 women in the first trimester of pregnancy from obstetric and
prenatal clinics in ten cities (11 study sites) across Canada from
2008 to 2011 (see Arbuckle et al. 2013 for additional details about
eligibility, recruitment, and follow-up). Briefly, eligibility criteria
included having the ability to consent and communicate in English
or French, being ≥18 y of age, having plans to deliver at a local
hospital, and agreeing to participate in the cord blood collection
component of the MIREC study. We excluded women who were
carrying a fetus with a known malformation or abnormality and
those with a history of major chronic disease, threatened abortion,
and illicit drug use. Of the 8,716 women we approached to partici-
pate in MIREC, 5,108 (58.6%) were eligible, 1,983 (38.8%) con-
sented to participate, and 1,910 had singleton live births. We
conducted follow-up on 896 (46.9%) singleton children born to
these women when the children were ∼ 3 y old.
This research was approved by ethics review boards from
Health Canada and Sainte-Justine Centre hospitalier universitaire
(CHU) and Quebec CHU research centers and by ethics commit-
tees at the participating hospitals. Potential participants were pro-
vided with information about the objectives and design of the
study and were asked to sign the informed consent forms for both
the prenatal and child follow-up portions of the study.
Prenatal BPA Exposure Assessment
We collected a single urine sample from women at an average of
12.1 wk gestation (range: 5:1–15wk), aliquoted the sample, froze
the aliquots at −20C within 2 h of collection, and shipped them
on dry ice to the MIREC coordinating center in Montreal, where
they were stored at −30C. Urine samples were shipped in
batches to the Centre de Toxicologie du Québec, Institut Na-
tional de Santé Publique du Québec for analysis. The total
(conjugated+ free) concentration of BPA was quantified using
previously described analytic chemistry methods (Arbuckle
et al. 2014). The limit of detection (LOD) for this method was
0.2 ng/mL, and we assigned values below the LOD a value of
0.1 ng/mL.
We accounted for individual variation in urine dilution by
measuring urine specific gravity (SG) with a refractometer and
standardizing urinary BPA concentrations using a formula





where Ps is the SG-standardized BPA concentration, Pi is the
observed BPA concentration for the i–th woman, SGm is the
median SG (1.013), and SGi is the observed SG for the i–th
woman.
Child Follow-up and Neurobehavioral Assessments
Among 1,910 singleton children, 896 (46.9%) from all 11
MIREC study sites participated in at least one component of our
child follow-up at an average age of 3.4 y (range: 2:8–4:2 y).
Among these children, almost all of them completed internet-
based or paper-and-pencil assessments of neurobehavior and
covariates (n=812 with complete exposure and covariate data).
Owing to limited resources, we conducted in-person assessments
of neurobehavior on children from seven MIREC study sites
(n=544 with complete exposure and covariate data). This in-
person visit typically occurred in the participant’s home, where
trained research personnel collected urine and blood from the
child, administered questionnaires, measured child anthropome-
try, and administered several neurobehavioral instruments to the
child. Variation in sample size arose from incomplete question-
naires (parents did not complete the surveys) or invalid adminis-
tration of in-person tests (e.g., inadequate testing environment).
We chose the tests described below for two reasons. First,
previous studies report that the traits they measure are associated
with prenatal exposure to environmental chemicals, including
BPA (Braun et al. 2011; Dietrich et al. 2005; Harley et al. 2013).
Second, some of these tests assess omnibus features of child neu-
rodevelopment (e.g., IQ), whereas other tests measure specific
features of clinical disorders such as attention deficit hyperactiv-
ity disorder (ADHD) (e.g., externalizing) and autism spectrum
disorder (ASD) (e.g., affect recognition) (Doyle et al. 1997;
Loukusa et al. 2014).
The questionnaire-based assessment included the administra-
tion of the Behavioral Assessment System for Children–2
(BASC-2) and two subscales from the Behavior Rating Inventory
of Executive Function–Preschool (BRIEF-P) to caregivers using
an internet-based platform or paper-and-pencil versions. The
BASC-2 is a valid and reliable 134-item assessment of children’s
problem behaviors in community and home settings (Reynolds
and Kamphaus 2002). It provides three composite scores that
measure children’s total [Behavioral Symptom Index (BSI)],
externalizing, and internalizing behavior problems, as well as
seven clinical subscales measuring children’s hyperactivity,
aggression, anxiety, depression, somatization, atypicality, with-
drawal, and attention. We assessed emerging metacognitive abil-
ities in children by parent report using 27 items from the working
memory and plan/organize subscales of the BRIEF-P, an instru-
ment originally designed to measure children’s executive func-
tion (Gioia et al. 2003). Women were not aware of their urinary
BPA concentration when they completed questionnaires about
their child’s behavior.
During the in-person assessment, parents completed the
Social Responsiveness ScaleE–2 (SRS-2), and children were
administered the Wechsler Preschool and Primary Scales of
IntelligenceE–III (WPPSI-III) and the Affect Recognition test
from the NEPSY® (A Developmental NEuroPSYchological
Assessment). The SRS-2 is a valid and reliable 65-item assess-
ment of reciprocal social behaviors including interpersonal
behaviors, communication, and repetitive or stereotypic behav-
iors (Bölte et al. 2008). The SRS-2 provides a summary scale of
all these behaviors, two scales of behaviors related to the
Diagnostic and Statistical Manual–V (DSM-V) diagnostic criteria
for autism spectrum disorders, and five subscales measuring
social awareness, social cognition, social communication, social
motivation, and restricted interests and repetitive behaviors.
During the in-home visit, we administered the WPPSI-III, a
valid and reliable assessment of children’s cognitive abilities
(Wechsler 2002). Children completed the Receptive Vocabulary,
Information, Block Design, Object Assembly, and Picture Naming
subtests of the WPPSI-III in their home. Finally, we administered
the Affect Recognition test of the NEPSY® during the in-home
visit. This test assesses a child’s ability to recognize emotions from
photographs of children’s faces; lower scores indicate that the child
has poor visual attention, visual discrimination, or facial recogni-
tion (Korkman et al. 2007). Study staff always attempted to provide
an ideal and standardized environment for administering the
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WPPSI-III and the NEPSY® in the home; this included ensuring
that the test area was well-lit, quiet, and free from distractions and
interruptions.
We used software provided by the test publishers and U.S.
population-based normative referent data to calculate full-scale
IQ (FSIQ), verbal IQ (VIQ), and performance IQ (PIQ) scores
for the WPPSI-III. Higher WPPSI-III scores indicate better cog-
nitive abilities. We used these same methods to calculate T-
scores for the BASC-2, the SRS-2, and the BRIEF-P. For these
three tests, higher T-scores indicate more of the behavior or
poorer functioning. Finally, we calculated scale scores for the
Affect Recognition test of the NEPSY®: higher scores indicate
better recognition of emotions.
Covariates
We assessed numerous factors that might confound the associa-
tion between prenatal urinary BPA concentration and child neu-
robehavior. Trained interviewers administered standardized
interviews during the first and third trimesters to assess maternal
age at delivery, maternal race, maternal education, marital status,
maternal employment, household income, self-reported smoking
during pregnancy, alcohol consumption, multivitamin use, and
parity. At the time of the child assessment, mothers completed
standardized questionnaires or assessments that measured the
duration of breastfeeding, parenting stress (Parenting Relation-
ship Questionnaire), depressive symptoms (Center for Epi-
demiological Studies–Depression Scale 10), and self-reported
delinquent behavior during adulthood. We also administered the
Home Observation for the Measurement of the Environment
(HOME) Inventory, a semi-structured interview that measures
the quality and quantity of the caregiving environment (Bradley
et al. 1988).
We identified confounders by using directed acyclic graphs
(DAGs) to select variables that were associated with both urinary
BPA concentration and at least one neurobehavioral outcome, but
not those that were causal intermediates or colliders (see Figure
S1). We used the same set of covariates for all analyses. We also
considered adjusting for study site because urinary BPA concen-
trations and measurement of children’s behavior or cognitive
abilities might vary across the study sites.
Statistical Methods
We began our statistical analyses by describing the central
tendency and distribution of maternal urinary BPA concentra-
tions and children’s BSI, FSIQ, and SRS total scores by covari-
ates. We examined the shape of the relationship between log2-
transformed urinary BPA concentration and neurobehavioral
scores using 3-knot restricted cubic polynomial splines. We
used multivariable linear regression to estimate the covariate-
adjusted association between log2-transformed urinary BPA
concentration and neurobehavioral scores. In addition, we
examined quintiles of urinary BPA concentration in relation-
ship to some neurobehavioral outcomes to characterize the
dose–response relationship. We used product interaction terms
between child sex and prenatal urinary BPA concentration to
estimate sex-specific associations and to test the difference in
these associations between boys and girls.
We examined the impact of adjusting for study site by com-
paring models that did not adjust for study site, that included
study site as a covariate, or that used generalized estimating equa-
tions (GEEs) to account for study site. Ultimately, we did not
adjust for study site because adjusting for this variable did not
meaningfully change our results, and the models using GEEs pro-
duced imprecise results when we examined quintiles of BPA
exposure because of small sample sizes at one study site. We
examined the magnitude and precision of individual point esti-
mates as well as the pattern of estimates across neurobehavio-
ral tests rather than relying solely on statistical significance
testing.
We conducted a series of sensitivity analyses to assess the
robustness of our results to various confounder adjustments.
First, we compared our results with and without adjustment for
covariates that were measured at the child follow-up visit (mater-
nal depression, parenting stress, breastfeeding duration, and
delinquent behavior) because these covariates may not be associ-
ated with prenatal urinary BPA concentration. Second, we
adjusted for maternal receipt of welfare support (n=18) and
child age. Third, among children who completed the in-person
visit, we adjusted for daycare attendance and the HOME
Inventory. To avoid potential selection biases, we made compari-
sons between models adjusted for our primary covariates and
those adjusted for our primary covariates plus daycare attendance
and the HOME Inventory among the subset of children who com-
pleted the in-person follow-up. We also examined whether our
method of accounting for urine dilution influenced our results by
comparing results of models that adjusted for creatinine as a
covariate with those that used SG-standardized BPA concentra-
tions. Finally, because urinary BPA and phthalate metabolite con-
centrations may be correlated because of shared exposure sources
(e.g., diet), and prenatal phthalate exposure may be associated
with adverse neurodevelopment, we adjusted for maternal urinary
concentrations of mono-ethyl phthalate, mono-n-butyl phthalate,
mono-benzyl phthalate, and the sum of three di-2-ethylhexyl
phthalate metabolites (Factor-Litvak et al. 2014; Miodovnik et al.
2014).
Results
Compared with mothers whose children did not complete follow-
up,mothers of childrenwho completed follow-up at 3 y of agewere
more likely to be older, white, better educated, married or living
with their partner, employed, nonsmokers during pregnancy, and to
use folic-acid supplements during pregnancy (see Table S2).
Baseline maternal covariates were not substantially different
among women whose children completed the questionnaire-
based follow-up vs. in-person follow-up. Median maternal uri-
nary BPA concentrations were similar among women who did
(0.8 ng/mL; 25th percentile: 0:3, 75th percentile: 1:6) and did not
(0.9 ng/mL; 25th: 0.4, 75th: 1.8) complete follow-up.
Among mothers whose children completed follow-up, uri-
nary BPA concentration during pregnancy ranged from <LOD
to 79.1 ng/mL, and 86% of women had detectable concentra-
tions. Median urinary BPA concentration did not substantially
vary with covariates (Table 1). Mean BSI, SRS, and FSIQ
scores were 51 [standard deviation ðSDÞ=7], 45 (SD=6), and
107 (SD= 14), respectively. FSIQ scores were higher than the
expected mean of 100, whereas SRS scores were lower than the
expected mean of 50. Mean BSI, SRS, and FSIQ scores differed
with several covariates. On average, FSIQ scores were lower and
BSI and SRS scores were higher among children whose mothers
were less educated, had lower household income, had greater par-
enting stress, and had more depressive symptoms.
We observed linear associations between prenatal urinary
BPA concentrations and children’s behavior or cognitive ability
scores (results not shown, all nonlinear term p-values> 0:08
from spline models). Among all children and after adjustment for
covariates, we observed few notable associations between prena-
tal urinary BPA concentration during pregnancy and children’s
BASC-2, BRIEF-P, WPPSI-III, and NEPSY® scores (Table 2).
However, child sex modified the associations between prenatal
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urinary BPA concentration during pregnancy and internalizing
and somatization scores on the BASC-2, as well as working
memory and plan/organize scores on the BRIEF-P (effect mea-
sure modification p-values< 0:10). In boys, each doubling in pre-
natal urinary BPA concentration was associated with more
internalizing (b=0:5; 95% CI: −0:1, 1.1) and somatizing (b=
0:6; 95% CI: 0.0, 1.2) behaviors as well as with poorer BRIEF-P
working memory (b=1:0; 95% CI: 0.3, 1.7) and plan/organize
(b=0:6; 95% CI: −0:1, 1.2) scores, whereas the associations
were null or slightly inverse in among girls (Table 2).
For those BASC-2 scales exhibiting associations with prenatal
urinary BPA concentration in boys, we further charac-terized the
shape of the dose–response relationship using quintiles of prenatal
urinary BPA concentration. Among boys, we observed a mono-
tonic dose–response relationship between prenatal urinary BPA
concentration and somatization score but not between prenatal
urinary BPA concentration and internalizing, plan/organize, or
working memory scores (Figure 1; see also Table S3). For exam-
ple, the mean somatization score among boys increased monotoni-
cally across all 5 quintiles of prenatal urinary BPA concentration,
Table 1. Central tendency and variation of maternal urinary BPA concentration during pregnancy and child BASC-2 BSI, SRS total, and WPPSI-III FSIQ
scores at 3 y of age according to covariates: MIREC study.
Variable
BPA BSI SRS FSIQ
n Median (25th, 75th) n Mean (SD) n Mean (SD) n Mean (SD)
Overall 812 0.8 (0.5, 1.5) 808 51 (7) 537 45 (6) 541 107 (14)
Maternal age, years
18–25 26 1 (0.6, 2.2) 26 50 (4) 14 48 (7) 15 103 (12)
>25–35 493 0.8 (0.5, 1.5) 490 51 (7) 339 46 (6) 340 107 (14)
>35 293 0.8 (0.4, 1.3) 292 50 (7) 184 45 (6) 186 107 (14)
Maternal Race
White 702 0.8 (0.5, 1.5) 700 51 (7) 462 45 (6) 462 108 (13)
Asian/Pacific Islander 27 0.5 (0.3, 1.2) 27 51 (6) 15 46 (5) 16 109 (11)
Other 49 0.8 (0.4, 1.4) 47 51 (8) 36 48 (6) 39 96 (14)
Multiracial 34 0.7 (0.4, 1.5) 34 50 (6) 24 46 (6) 24 107 (15)
Maternal education
Graduate degree 229 0.7 (0.4, 1.3) 229 50 (6) 145 44 (5) 146 110 (12)
University degree 325 0.9 (0.5, 1.5) 324 51 (7) 221 45 (7) 222 108 (14)
Some college, trade school, or diploma 214 0.8 (0.5, 1.8) 211 51 (7) 147 46 (6) 148 103 (14)
High school or less 44 0.9 (0.4, 1.6) 44 51 (8) 24 47 (7) 25 99 (11)
Marital status
Married or living with partner 791 0.8 (0.5, 1.4) 788 50 (7) 520 45 (6) 524 107 (14)
Not married or living alone 21 1 (0.7, 2) 20 54 (9) 17 49 (7) 17 101 (15)
Household Income (CAD)
>100,000 330 0.8 (0.5, 1.3) 329 50 (7) 215 44 (6) 217 109 (13)
80,000 to 100,000 270 0.8 (0.4, 1.4) 269 51 (7) 175 45 (6) 176 106 (14)
40,000 to<80,000 136 0.9 (0.6, 2.1) 134 51 (6) 92 47 (7) 93 103 (14)
<40,000 76 1 (0.5, 1.9) 76 52 (8) 55 48 (6) 55 104 (14)
Employment
No 93 0.9 (0.5, 1.7) 93 52 (8) 61 47 (9) 61 102 (17)
Yes 719 0.8 (0.5, 1.4) 715 50 (7) 476 45 (6) 480 107 (13)
Parity
0 357 0.9 (0.5, 1.6) 355 51 (7) 236 46 (6) 239 108 (14)
1 332 0.7 (0.4, 1.4) 330 51 (7) 217 45 (6) 217 106 (14)
≥2 123 0.8 (0.5, 1.2) 123 50 (6) 84 45 (7) 85 103 (12)
Maternal smoking
No 783 0.8 (0.5, 1.5) 779 51 (7) 521 45 (6) 525 107 (13)
Yes 29 0.8 (0.6, 1.5) 29 51 (9) 16 49 (7) 16 98 (16)
Prenatal alcohol use
No 448 0.8 (0.5, 1.5) 445 51 (6) 306 45 (6) 309 106 (14)
Yes 364 0.8 (0.5, 1.4) 363 50 (7) 231 45 (6) 232 108 (13)
Prenatal folic acid supplement use
No 534 0.8 (0.5, 1.5) 531 51 (7) 362 45 (6) 367 106 (14)
Yes 278 0.8 (0.4, 1.4) 277 50 (7) 175 45 (6) 174 108 (13)
Duration of exclusive breastfeeding, months
≥6 416 0.8 (0.5, 1.3) 415 51 (6) 266 45 (6) 268 108 (13)
<6 396 0.9 (0.5, 1.6) 393 51 (7) 271 46 (6) 273 105 (14)
Parenting Stress
Low 682 0.8 (0.5, 1.4) 681 49 (6) 448 44 (5) 450 108 (13)
High 130 0.9 (0.4, 1.7) 127 56 (7) 89 52 (8) 91 102 (17)
Maternal delinquency after high school
No delinquent behaviors 662 0.8 (0.4, 1.4) 659 50 (6) 429 45 (6) 432 108 (14)
Any delinquent behaviors 150 1 (0.5, 1.7) 149 53 (8) 108 47 (7) 109 104 (14)
Maternal CES-D Score
<16 785 0.8 (0.4, 1.4) 782 50 (7) 518 45 (6) 522 107 (14)
≥16 27 1 (0.8, 1.8) 26 54 (7) 19 48 (5) 19 107 (12)
Child sex
Male 399 0.8 (0.5, 1.5) 397 51 (7) 262 46 (7) 266 104 (15)
Female 413 0.8 (0.4, 1.4) 411 50 (6) 275 44 (5) 275 109 (12)
Note: BPA, bisphenol A; BASC-2, Behavioral Assessment System for Children–2; BSI, behavior symptom index of the BASC-2; CES-D, Center for Epidemiologic Studies
Depression Scale; FSIQ, full-scale IQ of the Wechsler Preschool and Primary Scales of Intelligence; MIREC, Maternal–Infant Research on Environmental Chemicals; SD, standard
deviation; SRS, total T-Score from the Social Responsiveness ScaleE; WPPSI-III, Wechsler Preschool and Primary Scales of IntelligenceE, 3rd edition.
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whereas internalizing scores were 2.4 points (95% CI: −0:1, 4.9)
higher among boys in the fourth quintile than those among boys in
the first quintile, but only 0.9 points (95% CI: −1:7, 3.5) higher
among boys in the fifth quintile.
Each doubling in prenatal urinary BPA concentration during
pregnancy was associated with higher scores on the SRS-2
among all children; the association was not modified by child
sex (effect measure modification p-values > 0:22) (Table 2).
Although SRS-2 scores tended to increase across prenatal urinary
BPA quintiles, the increases were not consistently monotonic
(Figure 2, see also Table S4). For example, children in the sec-
ond, third, fourth, and fifth quintiles of prenatal urinary BPA con-
centration had DSM-V social behavior scores that were 0.8 (95%
CI: −0:5, 2.2), 0 (95% CI: −1:0, 1.3), 1.2 (95% CI: −0:1, 2.6),
and 1.5 (95% CI: 0.1, 2.9) points higher, respectively, than chil-
dren in the first quintile. The associations between prenatal uri-
nary BPA concentration and SRS scores related to social
behaviors were stronger in boys than in girls, but the lowest
sex×BPA p-value was 0.2174. Prenatal urinary BPA concentra-
tion was associated with poorer NEPSY®–II Affect Recognition
score, but the 95% CI of the point estimate included the null value
[b= − 0:1 (95% CI: −0:2, 0.1)].
In sensitivity analyses, adjusting for covariates collected at 3 y
of age, welfare receipt, child age, or HOME Inventory score
generally did not appreciably change the results of our analyses for
SRS scores or BASC-2 internalizing scores (see Figures S2 and
S3).Although the association betweenBPAconcentration andSRS
scores was slightly attenuated after adjustment for welfare, the
magnitude of these differences was≤0:1 points. For example, after
adjustment forwelfare, the association betweenBPAconcentration
and Social Cognition score was 0.3 (95% CI: −0:1, 0.6), compared
with 0.4 (95% CI: 0, 0.7) before adjustment. Associations between
BPA concentration and internalizing or somatization score were
unchanged when we accounted for urine dilution by adjusting for
log10-transformed creatinine concentration (see Figure S3); how-
ever, the associations between prenatal urinary BPA concentration
and SRS scores were attenuated but more precise when adjusting
for creatinine compared with using SG-standardized concentra-
tions (see Figure S2). Adjustment for phthalate concentration did
not substantially alter the associations of BPAwith internalizing or
SRSscores (seeFigures S2 andS3).
Discussion
In this cohort, we observed that prenatal urinary BPA concentra-
tion was associated with poorer parent-reported reciprocal social
behaviors as measured by the SRS-2 among both boys and girls.
Furthermore, we observed some sex-specific associations where
increasing prenatal urinary BPA concentration was positively
Table 2. Adjusted difference in behavioral and cognitive test score at 3 y of age with doubling in specific gravity standardized maternal urinary BPA
concentrations during pregnancy: MIREC study.
Neurodevelopmental test n All children: b (95% CI) Boys: b (95% CI) Girls: b (95% CI) BPA×Sex p-value
BASC-2 Summary Scales
BSI 808 0:1 ð−0:1, 0:4Þ 0:3 ð−0:2, 0:7Þ 0:1 ð−0:3, 0:4Þ 0.5349
Externalizing 808 0:0 ð−0:4, 0:3Þ 0:1 ð−0:4, 0:6Þ −0:1 ð−0:5, 0:4Þ 0.6268
Internalizing 806 0:1 ð−0:3, 0:5Þ 0:5 ð−0:1, 1:1Þ −0:2 ð−0:7, 0:3Þ 0.0817
BASC-2 Clinical Scales
Hyperactivity 809 0:0 ð−0:4, 0:3Þ 0:1 ð−0:5, 0:6Þ −0:1 ð−0:5, 0:4Þ 0.7262
Aggression 808 0:0 ð−0:3, 0:4Þ 0:2 ð−0:4, 0:7Þ 0:0 ð−0:5, 0:5Þ 0.6046
Anxiety 803 0:0 ð−0:4, 0:5Þ 0:0 ð−0:7, 0:8Þ 0:0 ð−0:6, 0:6Þ 0.8772
Depression 808 0:3 ð−0:1, 0:7Þ 0:5 ð−0:1, 1:1Þ 0:2 ð−0:4, 0:7Þ 0.3722
Somatization 808 0:0 ð−0:4, 0:4Þ 0.6 (0.0, 1.2) −0:5 ð−1:0, 0:0Þ 0.0063
Atypicality 809 0:1 ð−0:3, 0:4Þ 0:3 ð−0:2, 0:9Þ −0:1 ð−0:6, 0:3Þ 0.1871
Withdrawal 806 0:2 ð−0:2, 0:6Þ 0:0 ð−0:6, 0:6Þ 0:4 ð−0:2, 0:9Þ 0.3666
Attention 812 0:0 ð−0:1, 0:2Þ 0:1 ð−0:1, 0:4Þ 0:0 ð−0:2, 0:2Þ 0.5395
BRIEF-P
Working Memory 810 0:1 ð−0:3, 0:6Þ 1.0 (0.3, 1.7) −0:5 ð−1:1, 0:1Þ 0.0009
Plan/Organize 812 0:0 ð−0:5, 0:4Þ 0:6 ð−0:1, 1:2Þ −0:5 ð−1:0, 0:1Þ 0.0258
WPPSI-III Summary Scales
FSIQ 541 0:1 ð−0:7, 0:9Þ 0:7 ð−0:4, 1:9Þ −0:3 ð−1:4, 0:7Þ 0.1710
VIQ 538 −0:2 ð−1:0, 0:5Þ 0:3 ð−0:8, 1:4Þ −0:7 ð−1:7, 0:3Þ 0.1660
PIQ 536 0:6 ð−0:3, 1:5Þ 1:1 ð−0:3, 2:4Þ 0:2 ð−1:0, 1:4Þ 0.3433
WPPSI-III Subtests
Vocabulary 544 −0:1 ð−0:2, 0:1Þ 0:1 ð−0:2, 0:3Þ −0:1 ð−0:4, 0:1Þ 0.2259
Block Design 541 0:1 ð−0:1, 0:3Þ 0:2 ð−0:1, 0:4Þ 0:0 ð−0:2, 0:3Þ 0.4635
Information 531 0:0 ð−0:2, 0:1Þ 0:1 ð−0:2, 0:3Þ −0:1 ð−0:3, 0:1Þ 0.2088
Object Design 541 0:1 ð−0:1, 0:3Þ 0:2 ð−0:1, 0:4Þ 0:0 ð−0:2, 0:3Þ 0.3552
Picture Completion 541 0:1 ð−0:1, 0:2Þ 0:2 ð−0:1, 0:4Þ 0:0 ð−0:2, 0:2Þ 0.2863
SRS-2
Total 537 0.3 (0.0, 0.7) 0.5 (0.1, 1.0) 0:2 ð−0:2, 0:6Þ 0.3090
Awareness 537 0:4 ð−0:1, 0:8Þ 0.6 (0.0, 1.3) 0:2 ð−0:4, 0:7Þ 0.3008
Cognition 537 0.3 (0.0, 0.6) 0.5 (0.0, 1.0) 0:2 ð−0:3, 0:6Þ 0.4361
Communication 537 0.4 (0.0, 0.7) 0.5 (0.1, 1.0) 0:2 ð−0:2, 0:6Þ 0.2777
Motivation 537 0:2 ð−0:2, 0:6Þ 0:3 ð−0:3, 1:0Þ 0:0 ð−0:5, 0:6Þ 0.4628
Restricted 537 0.4 (0.0, 0.7) 0:4 ð−0:2, 0:9Þ 0:3 ð−0:2, 0:8Þ 0.8306
DSM Social 537 0.3 (0.0, 0.6) 0.5 (0.1, 1.0) 0:2 ð−0:3, 0:6Þ 0.2174
DSM Restricted 537 0.4 (0.0, 0.7) 0:4 ð−0:2, 0:9Þ 0:3 ð−0:2, 0:8Þ 0.8353
NEPSY®: Affect Recognition 497 −0:1 ð−0:2, 0:1Þ 0:1 ð−0:2, 0:3Þ −0:1 ð−0:3, 0:0Þ 0.1620
Note: Adjusted for maternal race, education, age, marital status, employment, smoking during pregnancy, alcohol use during pregnancy, folic acid supplement use during pregnancy,
parity, months of exclusive breastfeeding, parental stress, and depressive symptoms. Positive coefficients for the BASC-2, BRIEF-P, and SRS indicate that BPA concentrations are
associated with more behavior problems. Positive coefficients for the WPPSI-III and NESPY indicate that BPA is associated with better performance. BASC-2, Behavioral
Assessment System for Children–2; BRIEF-P, Behavior Rating Inventory of Executive Function–Preschool; BPA, bisphenol A; BSI, behavior symptom index of the BASC-2; CI, con-
fidence interval; DSM, Diagnostic and Statistical Manual of Mental Disorders; FSIQ, full-scale IQ; MIREC, Maternal–Infant Research on Environmental Chemicals; NEPSY®, A
Developmental NEuroPSYchological Assessment; PIQ, performance IQ; SRS, Social Responsiveness ScaleE, 2nd Edition; VIQ, verbal IQ; WPPSI, Wechsler Preschool and Primary
Scales of IntelligenceE–III.
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correlated with more parent-reported somatization and internaliz-
ing behaviors and poorer parent-reported working memory and
planning/organizing skills in boys, but not in girls. The associa-
tions between maternal urinary BPA concentration during preg-
nancy and other measures of children’s cognitive abilities and
behavior at 3 y of age were largely null.
Our study adds to a number of modestly sized studies
(n=137− 438) examining prenatal BPA exposure and child neu-
robehavior (Braun et al. 2011; Casas et al. 2015; Evans et al.
2014; Harley et al. 2013; Miodovnik et al. 2011; Roen et al.
2015). The sample size of the present study is a notable strength
because it allowed us to more precisely estimate the presence and
nature of sex-specific associations compared with prior studies.
Consistent with the present results, four studies from three pro-
spective cohorts reported that increasing prenatal urinary BPA
concentration was associated with either internalizing or somatiz-
ing behaviors in children, with stronger associations in boys than
in girls (Evans et al. 2014; Harley et al. 2013; Perera et al. 2012;
Roen et al. 2015). In another cohort, prenatal BPA concentration
was associated with more internalizing and externalizing behaviors
in girls, but not in boys (Braun et al. 2009, 2011). Another study
found that prenatal BPA concentration was associated with an
increased risk of ADHD-related behaviors at 4 y of age, with
stronger associations in boys (Casas et al. 2015).
Previous studies have not reported associations between pre-
natal urinary BPA concentration and cognitive outcomes in chil-
dren (Braun et al. 2011; Casas et al. 2015). The findings of Casas
et al. (2015) are consistent with our results of no association of
prenatal BPA with child IQ or specific subtests of the WPPSI-III.
Although we did observe an association of prenatal urinary BPA
concentration with working memory and plan/organize scores in
boys, a prior study using the BRIEF-P did not find an association
(or modification by child sex) between prenatal urinary BPA con-
centration and working memory or plan/organize scores on the
BRIEF-P (Braun et al. 2011).
Two prior studies reported that prenatal urinary BPA concen-
tration was not associated with parent-reported reciprocal social
behaviors and that these associations did not differ with respect
to child sex (Braun et al. 2014; Miodovnik et al. 2011). In con-
trast, we observed poorer reciprocal social behaviors among
Figure 1. Covariate adjusted mean child BASC-2 and BRIEF-P scores by maternal urinary BPA quintile: MIREC Study. Adjusted for maternal race, education,
age, marital status, employment, smoking during pregnancy, alcohol use during pregnancy, folic acid supplement use, parity, months of exclusive breastfeed-
ing, parental stress, and depressive symptoms. Maternal urinary BPA concentrations are specific-gravity standardized. Quintile ranges were 0:1 to<0:4 ng=mL,
0:4 to <0:7 ng=mL, 0:7 to<1:0 ng=mL, 1:0 to<1:7 ng=mL, and 1.7 to 79 ng/mL. Error bars represent the 95% confidence intervals. n=806, 805, 810, and 812
for internalizing, somatization, plan/organize, and working memory, respectively. Note: The y-axis scale changes in each row. BASC-2, Behavioral
Assessment System for Children–2; BPA, bisphenol A; BRIEF-P, Behavior Rating Inventory of Executive Function-Preschool; MIREC, Maternal–Infant
Research on Environmental Chemicals.
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children born to women with higher prenatal urinary BPA con-
centrations. It should be noted that the associations between pre-
natal BPA concentration and SRS scores in this study were
relatively modest, did not increase monotonically, and were typi-
cally largest in magnitude when comparing the fourth or fifth
quintile with the first. There are several possible reasons for dis-
crepant results across this and prior studies. First, urinary BPA
concentration was lower among women in this study compared
with most previous studies (median: 0.8 vs. ∼ 2 ng=mL) and in
contrast to prior studies, we may have not had sufficient BPA ex-
posure variation to detect associations. Second, although the dif-
ferent neurobehavioral assessments used across studies could be
a source of variation, it will depend on the specific instrument
and domain. For instance, externalizing and internalizing scores
on the BASC-2 and those on the Child Behavior Checklist tend
to be highly correlated (Pearson R>0:68); in contrast, for some
clinical domains, such as anxiety, the correlations are lower
(Pearson R<0:35) (Reynolds and Kamphaus 2002). Third, the
timing and number of prenatal urinary BPA measures during
pregnancy could influence study results if there are periods of
heightened vulnerability to BPA exposure. One animal study
observed that BPA exposure during organogenesis and breast-
feeding caused morphine-induced hyperlocomotion, preference
for drug-paired place, and up-regulation of dopamine receptor
function, whereas exposure at other gestational time periods did
not (Narita et al. 2006). However, there does not appear to be an
obvious pattern between the observed epidemiological results
and the timing of exposure assessment in this and prior studies.
Finally, the timing of the neurobehavioral assessment could influ-
ence study results for traits that change as children age (e.g., anxi-
ety) (Merikangas et al. 2010). Thus, associations between early-
life toxicant exposure and child neurobehavior may not manifest
until later in life; this phenomenon has been observed for other
neurotoxicants such as polybrominated diphenyl ethers and meth-
ylmercury (Chen et al. 2014; Karagas et al. 2012).
Given the episodic nature of BPA exposure and its short bio-
logical half-life (<6 h), there is substantial within-person varia-
tion of urinary BPA concentrations that makes accurate exposure
assessment in epidemiological studies challenging (Braun et al.
2012; Thayer et al. 2015). Thus, nondifferential BPA exposure
misclassification may be responsible not only for attenuation of
observed associations but also for heterogeneity in the literature.
Our study measured BPA in only one urine sample from each
woman, and this likely led to misclassification of the women’s
BPA exposure. A simulation study found that the high within-
person variation of a urinary biomarker such as BPA leads to
associations being biased toward the null and that it might be nec-
essary to obtain ≥10 repeated urine biomarkers from an individ-
ual or to analyze a pooled sample from each individual to limit
bias in the effect estimate (Perrier et al. 2016). Other approaches,
including regression calibration techniques, could be used to
account for nondifferential exposure measurement error in studies
with only a single estimate of exposure for all participants and
repeated measures on a subset.
We were unable to examine potential mechanisms of BPA
action in this study but could do so in the future using stored bio-
specimens available in the MIREC Study (Arbuckle et al. 2013).
Prenatal BPA exposure may adversely affect a variety of biologi-
cal processes during fetal development that are essential for
proper neurodevelopment. In animal studies, BPA can affect the
synthesis, action, transport, or metabolism of neurotransmitters,
gonadal hormones, and thyroid hormones (Milligan et al. 1998;
Tian et al. 2010; Zhang et al. 2011; Zoeller et al. 2005). BPA is a
weak agonist of the nuclear estrogen receptors a and b and may
affect androgen/estrogen concentrations by inhibiting key enzymes
involved in steroidogenesis (Milligan et al. 1998; Zhang et al.
2011). The ability of BPA to act on gonadal hormones may
explain the sexually dimorphic associations we and others have
observed because gonadal hormones play an important role in neu-
rodevelopment (Cohen-Bendahan et al. 2005). Other potential
mechanisms of BPA action may include disruption of thyroid hor-
mone homeostasis. In two epidemiological studies, prenatal uri-
nary BPA concentration was associated with reduced neonatal
thyroid stimulating hormone concentration, but the associations
were observed in girls in one study and in boys in the other
(Chevrier et al. 2013; Romano et al. 2015).
We observed relatively modest associations between prenatal
urinary BPA concentration and specific aspects of child neurobe-
havior, particularly when considered from a clinical perspective.
Despite this modest association, even subtle effects of BPA expo-
sure could shift the distribution of continuous neurobehavioral
traits to increase the risk of disorders such as autism spectrum dis-
orders at the population level (Bellinger 2004). Indeed, Bellinger
has shown that despite the modest associations between some
environmental toxicants and neurobehavioral traits at the clinical
level, the ubiquitous nature of these exposures results in effects at
the population level that are comparable to or exceed the
population-level effects of clinical risk factors (e.g., preterm birth
or iron deficiency) (Bellinger 2012).
We comprehensively assessed numerous features of child-
ren’s behaviors related to several neurodevelopmental disorders
(e.g., anxiety, depression, ADHD, and ASD) and specific cogni-
tive abilities. This is a notable strength because the majority of
Figure 2. Covariate adjusted mean child SRS-2 scores by maternal urinary
BPA quintile: MIREC Study (n=537). Adjusted for maternal race, education,
age, marital status, employment, smoking during pregnancy, alcohol use during
pregnancy, folic acid supplement use, parity, months of exclusive breastfeeding,
parental stress, and depressive symptoms. Maternal urinary BPA concentrations
are specific-gravity standardized. Quintile ranges were 0:1 to<0:4, 0:4 to<0:7,
0:7 to<1:0, 1:0 to<1:7, and 1.7 to 79 ng/mL. Error bars represent the 95% confi-
dence intervals. Note: The y-axis scale changes in each row. BPA, bisphenol A;
BRIEF-P, Behavior Rating Inventory of Executive Function-Preschool;MIREC,
Maternal–Infant Research on Environmental Chemicals; RI/RB, restricted inter-
ests/repetitivebehaviors.
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previous studies have only examined child behavior. However,
our assessment of children’s behaviors, working memory, and
planning/organizing was limited to parental reports and could be
enhanced in future studies by employing objective or teacher-
reported measures of these domains.
A limitation of our study is that we were unable to adjust for
other predictors of child behavior and cognition, specifically pa-
rental behavior and cognitive abilities. We note that adjustment
for our primary set of covariates modestly attenuated the associa-
tion between prenatal urinary BPA concentration and children’s
SRS scores, but additional adjustment for maternal receipt of
welfare, caregiving environment, or daycare attendance did not
appreciably change these associations. Thus, although residual
confounding by other determinants of child neurobehavior is pos-
sible, these other factors would need to explain additional varia-
tion in our outcomes beyond those variables we adjusted for in
our models and be associated with prenatal BPA exposure.
Finally, we only assessed BPA exposure during the first tri-
mester of pregnancy, whereas exposure during other periods of
fetal development, infancy, or childhood might affect neurodevel-
opment. Some previous studies have reported that childhood
urinary BPA concentration is associated with child behaviors
(Harley et al. 2013; Tewar et al. 2016). Thus, identifying other
periods of heightened vulnerability to BPA exposure in both the
prenatal and postnatal periods remains an avenue of future
research.
Conclusion
In the present study, maternal urinary BPA concentration during
pregnancy was associated with some aspects of children’s behav-
iors at 3 y of age: specifically, poorer reciprocal social behaviors
among all children, more internalizing and somatization behav-
iors in boys, and poorer working memory and planning/orga-
nizing abilities in boys. Urinary BPA concentration during preg-
nancy was not associated with affect recognition, IQ, or external-
izing behaviors, nor were these associations modified by child
sex. Future investigations of early-life BPA exposure and child
neurobehavior will need to reduce BPA exposure misclassifica-
tion by conducting more extensive urine biomonitoring or by
using measurement error correction methods.
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